Carbidopa and Levodopa Enteral Suspension and MitoMYcin (Systemic)
Determining the interaction of Carbidopa and Levodopa Enteral Suspension and MitoMYcin (Systemic) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
Generic Name: mitomycin
Brand name: Mutamycin
Synonyms: Mitomycin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Carbidopa and Levodopa Enteral Suspension-Mitomycin Intravenous
- Carbidopa and Levodopa Enteral Suspension-Mitotane
- Carbidopa and Levodopa Enteral Suspension-Mitoxantrone
- Carbidopa and Levodopa Enteral Suspension-Mitoxantrone Hydrochloride
- Carbidopa and Levodopa Enteral Suspension-Mitoxantrone Injection Concentrate
- Carbidopa and Levodopa Enteral Suspension-Mitoxantrone Intravenous, Injection
- MitoMYcin (Systemic)-Carbidopa and Levodopa Extended-Release Capsules
- MitoMYcin (Systemic)-Carbidopa and Levodopa Extended-Release Tablets
- MitoMYcin (Systemic)-Carbidopa and Levodopa ODT
- MitoMYcin (Systemic)-Carbidopa and Levodopa Orally Disintegrating Tablets
- MitoMYcin (Systemic)-Carbidopa and levodopa Route Not Applicable
- MitoMYcin (Systemic)-Carbidopa and Levodopa Tablets